Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
209
datasets available to search
ShareScore release 0.9.0
Dataset results
209 results for “Multiple Sclerosis (MS)”
Gregory-MS: list of research papers relevant/not relevant for Multiple Sclerosis research (for machine learning training)
<p>This dataset represents the list of research papers' data that was used to train and test different machine learning algorithms in the Gregory-MS project. The list includes the title and abstract (when available) of the research papers and an annotated field (relevant) that specifies if the given research paper is relevant or not for multiple sclerosis research.</p>
Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT01600716. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT03222973. IPD Sharing: Not stated. Countries: 15. Publications: 3.
Thyroid Hormone for Remyelination in Multiple Sclerosis (MS): A Safety and Dose Finding Study
ClinicalTrials.gov study NCT02760056. IPD Sharing: YES. Countries: 1. Publications: 1.
BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT00835770. IPD Sharing: Not stated. Countries: 34. Publications: 4.
Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx
ClinicalTrials.gov study NCT00211887. IPD Sharing: Not stated. Countries: 2. Publications: 12.
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
ClinicalTrials.gov study NCT02634307. IPD Sharing: Not stated. Countries: 10. Publications: 6.
Melatonin in Patients With Multiple Sclerosis (MS).
ClinicalTrials.gov study NCT03498131. IPD Sharing: NO. Countries: 1. Publications: 2.
Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT01188811. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2
ClinicalTrials.gov study NCT03093324. IPD Sharing: NO. Countries: 3. Publications: 3.
A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT00681538. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT02294058. IPD Sharing: Not stated. Countries: 25. Publications: 3.
A Phase 2 Study of Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD)
ClinicalTrials.gov study NCT00436826. IPD Sharing: Not stated. Countries: 4. Publications: 2.
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT03073603. IPD Sharing: NO. Countries: 1. Publications: 3.
Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT00537082. IPD Sharing: Not stated. Countries: 1. Publications: 2.
High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
ClinicalTrials.gov study NCT00288626. IPD Sharing: YES. Countries: 1. Publications: 11.
REbif FLEXible Dosing in Early Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT00404352. IPD Sharing: Not stated. Countries: 27. Publications: 5.
Evaluation of Quality of Life (QoL) in Subjects With Highly Active Relapsing Multiple Sclerosis (MS) (CLARIFY MS)
ClinicalTrials.gov study NCT03369665. IPD Sharing: YES. Countries: 18. Publications: 1.
Oral Cladribine in Early Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT00725985. IPD Sharing: Not stated. Countries: 34. Publications: 5.
Lipoic Acid for Progressive Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT03161028. IPD Sharing: NO. Countries: 2. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.